|
Volumn 44, Issue 6, 1997, Pages 524-525
|
Cost-effectiveness analysis [2]
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
ANTIBIOTIC THERAPY;
BACTERIAL INFECTION;
BRONCHITIS;
COST EFFECTIVENESS ANALYSIS;
HEALTH CARE COST;
HUMAN;
LETTER;
PREVALENCE;
ACUTE DISEASE;
COST BENEFIT ANALYSIS;
COUGHING;
ECONOMICS;
MICROBIOLOGY;
NOTE;
QUALITY OF LIFE;
TREATMENT OUTCOME;
ACUTE DISEASE;
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
BRONCHITIS;
COST-BENEFIT ANALYSIS;
COUGH;
HEALTH CARE COSTS;
HUMANS;
QUALITY OF LIFE;
TREATMENT OUTCOME;
|
EID: 0040007882
PISSN: 00943509
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (1)
|
References (4)
|